Home » Newsletters » BioWorld Science

BioWorld Science

May 25, 2020

View Archived Issues

Optimized benzoxazolone carboxamides for oral treatment of neurological lysosomal storage diseases

SIRPa blockade wakes up macrophages after infection

Lasting immunity to SARS-CoV-2 looks possible

RDIF and ChemRar launch final stage of favipiravir study in patients with COVID-19

Positive data from outpatient portion of a phase II study of RTU glucagon

Daiichi Sankyo presents new 5-HT2A receptor agonists

FDA accepts IND application for phase I/II study of NT-219 in advanced cancer

Beijing Tide Pharmaceutical patents ROCK2 inhibitors

Chinese investigators divulge coagulation factor XIa inhibitors

Roche synthesizes new TLR antagonists

Fidget spinner allows point-of-care diagnosis of UTIs

GlaxoSmithKline plc synthesizes new H-PGDS inhibitors

Phase I/II data presented for LY-500307 in men with schizophrenia

Serum KL-6 as a biomarker for the management of Mycobacterium avium complex lung disease

HCP5 is a diagnostic and prognostic marker in AML

Phase III trial of Dupixent for eosinophilic esophagitis meets coprimary endpoints

FDA approves Alunbrig for ALK-positive metastatic NSCLC

FDA approves Phexxi gel to prevent pregnancy

Phase I/II trial evaluates LS-301 uptake in breast cancer patients

A new oxime that crosses the blood-brain barrier as a treatment for organo-phosphate poisoning

Identification of a new peptide targeting the HR1 spike domain as a pan-coronavirus fusion inhibitor

Kynomycin, a methylated daptomycin analogue, shows promise for multidrug-resistant pathogens

First clinical data presented for PfSPZ-GA1 antimalarial vaccine

A human monoclonal antibody neutralizing SARS-CoV-2 and SARS-CoV infections

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Dec. 5, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Dec. 5, 2025.
Epigenetic technology could eliminate misfolded prion proteins
BioWorld Science
The number of deaths caused by prion diseases reaches about 30,000 annually. Only 5 months pass from the diagnosis of seemingly healthy patients to the fatal...
Mesothelin is biomarker, potential target in arthritic bone damage
BioWorld Science
In a recent study published in Cell Reports Medicine, researchers from the Institute of Chinese Materia Medica of the China Academy of Chinese Medical Sciences...
Cosmo data positive for first new hair-loss approach in decades
BioWorld
Shares of Cosmo Pharmaceuticals NV rose sharply on Dec. 3 following top-line pivotal phase III data showing a statistically significant and clinically meaningful...